StockData
BioNTech SE logo

BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$83.26−1.60 (-1.89%)

Close on Nov 18, 2026Market cap $20.92BP/E –Yield –

BioNTech free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was €280.90M. The highest annual figure on record is €13.25B in fiscal 2022.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025€280.90M–
FY2024Dec 31, 2024-€78.80M-101.5%
FY2023Dec 31, 2023€5.12B-61.3%
FY2022Dec 31, 2022€13.25B+1638.2%
FY2021Dec 31, 2021€762.20M–
FY2020Dec 31, 2020-€79.50M–
FY2019Dec 31, 2019-€237.10M–
FY2018Dec 31, 2018-€88.78M–
FY2017Dec 31, 2017-€76.88M–

More BioNTech figures

See a number that looks wrong?